hotspot -WSS

hotspot

author：focus 2025-10-01 06:01:16 - browse：7574

Vivistim and Lead — A small Texas company is testing whether pairing vagus nerve stimulation with rehabilitation exercise can restore movement in people who have had a stroke. STAT/MicroTransponder, Inc.

Despite being forced by Hurricane Irma to close its outpatient facilities for several days, the Mayo Clinic in Jacksonville, Fla., is expected to forge ahead this month with a pivotal clinical trial testing whether an electrical implant can rewire the brains of stroke patients so they can use their arms and hands again.

If the patients who receive implants regain significantly more function than those who get only standard rehabilitation, it will show that stroke-damaged brain circuits can be bypassed like shorts in a circuit board, with healthy neurons coaxed into performing the job of those fried by stroke.

Although the results might not be make-or-break for the little 11-year-old Texas company sponsoring the trial (called MicroTransponder, the company’s also testing whether an electrical implant can alleviate tinnitus), there will be more evidence of whether “electroceuticals” — electrical stimuli tailored to treat diseases — work beyond their current use in controlling pain and a few other conditions or will fall short of the buzz surrounding them.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： How I helped Pfizer think through the ethics of Viagra

WSS

Florida officials tell state schools to teach AP Psychology 'in its entirety'

How I helped Pfizer think through the ethics of Viagra

Chris Christie meets with Zelenskyy during Ukraine trip

When a patient nears the end, a feared therapy can comfort

A controversial new treatment promises to make little people taller

Judge partially blocks Texas abortion ban for medical emergencies, fatal diagnoses

entertainment

hotspot

entertainment

As demand for Covid shots wanes, Moderna seeks its next success

Judge denies Trump's request for new trial in E. Jean Carroll case

BioMarin wins approval for gene therapy to treat hemophilia A

Medicare slashes safety net hospital payments by nearly $1 billion

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

A controversial new treatment promises to make little people taller

Activists slam private health insurers over coverage restrictions

Group behind ProMed defends move to subscription

How to save PrEP access — and even expand it

FDA scientists endorse Pfizer/BioNTech Covid

explore

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

The stock market has soared this year, but will it last? Experts weigh in

Eli Lilly to acquire DICE Therapeutics in $2.4 billion deal

How I helped Pfizer think through the ethics of Viagra

'Golden Bachelor' Gerry Turner reveals what he wants in a partner and more

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

Wikipedia

hotspot

focus

knowledge